Therapy with FK 506 in pediatric liver recipients.
Rosh
J R
JR
Division of Pediatric, Mt Sinai Hospital, New York, NY 10029.
Schwersenz
A H
AH
Schwartz
M
M
Moran
V
V
Leleiko
N
N
LeLeiko
V M
VM
Miller
C M
CM
D000293:Adolescent; D001663:Bilirubin / Q000097:blood; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000009:adverse effects; D005260:Female; D006085:Graft Survival; D006801:Humans; D006947:Hyperkalemia / Q000209:etiology; D007165:Immunosuppression Therapy / Q000009:adverse effects / Q000379:methods; D007223:Infant; D007239:Infections / Q000209:etiology; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology; D008232:Lymphoproliferative Disorders / Q000209:etiology; D008297:Male; D012449:Safety; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*
D016572:Cyclosporine; D001663:Bilirubin; D016559:Tacrolimus